This study is looking at whether metabolic surgery can help people with atrial fibrillation (a type of irregular heartbeat) and obesity. You could be eligible if you are between 18 and 80 years old, have a body mass index (BMI) between 35 and 65, and have symptomatic atrial fibrillation. Participants will either receive metabolic surgery (Roux-en-Y Gastric Bypass or Sleeve Gastrectomy) or anti-obesity medication (AOM) treatment. The main goal is to see how much the total time you spend in atrial fibrillation changes over the first 52 weeks of the study. The study is currently unclear on its recruitment status and plans to enroll 100 people.

Study design

This is a randomized study with 100 participants. Patients will be randomly assigned to either the surgery group or the non-surgical control group.

What's involved

Participants will be followed for 12 months in the first phase, and then for an additional 18 months in a second phase. Interventions include either surgery or anti-obesity medications, along with personalized diet plans, exercise, and risk factor reduction.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 12 months, and then for an additional 18 months, for a total of 30 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.